Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2025-12-27 @ 2:04 PM
Study NCT ID:
NCT00589667
Status:
COMPLETED
Last Update Posted:
2014-04-02
First Post:
2007-12-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09
Start Date Type:
None
Primary Completion Date:
2010-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-26
First Submit QC Date:
None
Study First Post Date:
2008-01-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-23
Results First Submit QC Date:
None
Results First Post Date:
2014-03-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-05
Last Update Post Date:
2014-04-02
Last Update Post Date Type:
ESTIMATED